Dose-volume effects of breast cancer radiation therapy on the risk of second oesophageal cancer.

Abstract

PURPOSE

To investigate the relationship between oesophagus dose-volume distribution and long-term risk of oesophageal cancer after radiation therapy for breast cancer.

MATERIALS AND METHODS

In a case-control study nested within a cohort of 289,748 ≥5-year survivors of female breast cancer treated in 1943-2003 in five countries, doses to the second primary cancer (D_SPC) and individual dose-volume histograms (DVH) to the entire oesophagus were reconstructed for 252 oesophageal cancer cases and 488 matched controls (median follow-up time: 13, range: 5-37 years). Using conditional logistic regression, we estimated excess odds ratios (EOR) of oesophageal cancer associated with DVH metrics. We also investigated whether DVH metrics confounded or modified D_SPC-related -risk estimates.

RESULTS

Among the DVH metrics evaluated, median dose (D_median) to the entire oesophagus had the best statistical performance for estimating risk of all histological types combined (EOR/Gy = 0.071, 95% confidence interval [CI]: 0.018 to 0.206). For squamous cell carcinoma, the most common subtype, the EOR/Gy for D_median increased by 31% (95% CI: 3% to 205%) for each increment of 10% of V30 (p = 0.02). Adjusting for DVH metrics did not materially change the EOR/Gy for D_SPC, but there was a borderline significant positive interaction between D_SPC and V30 (p = 0.07).

CONCLUSION

This first study investigating the relationship between oesophagus dose-volume distribution and oesophageal cancer risk showed an increased risk per Gy for D_median with larger volumes irradiated at high doses. While current techniques allows better oesophagus sparing, constraints applied to D_median and V30 could potentially further reduce the risk of oesophageal cancer.